AfaSci, Inc., a San Francisco Bay Area biotech company committed to enhancing health care by conducting R&D in both Biotechnology and Therapeutics. Our bioengineering team has designed, produced and been marketing an in vivo drug screening platform, SmartCageTM. This system enables automated, and objective assessment of drug effects on rodent behavior and increases throughput of phenotyping of transgenic animals. Elevating our proprietary platform and well-established electrophysiological techniques, AfaSci’s scientists have been discovering IND drug candidates targeting ion channels and GPCR for the treatment of CNS disorders, especially neuropathic pain, epilepsy and Alzheimer’s disease.
Company Details
- Employees
- 17
- Founded
- -
- Address
- 522 Second Avenue, Redwood City,california 94063,united States
- Phone
- (415) 480-4138
- in****@****sci.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- afasci.com
- HQ
- Redwood City, California
Afasci, Inc. Questions
Afasci, Inc.'s helpline number is (415) 480-4138
Afasci, Inc.'s website is afasci.com
Afasci, Inc.'s LinkedIn profile is https://www.linkedin.com/company/afasci-inc-
Afasci, Inc. has
17 employees.
View email and phone details for 17
employees at Afasci, Inc..
Afasci, Inc.'s industry is
Biotechnology Research
Afasci, Inc.'s top competitors are
Nexgenegirls,
四川百利药业有限公司,
Epiodyne,
Supercede Therapeutics, Inc.,
Xinthera, Inc.,
红日药业,
Arcus Biosciences,
Corregene Biotechnology,
Khartis Therapeutics, Inc.,
Wuxi Extpure Solutions Co., Ltd.
Afasci, Inc.'s support email address is inquiries@afasci.com
Afasci, Inc.'s categories are Biotechnology Research
Afasci, Inc.'s founding year is 2003
